Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 4:10 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2137–2160 of 17,766 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Population Clear all

Conditions: Aneuploidy
Interventions: non-invasive prenatal testing; Other
Lead sponsor: Obstetrix Medical Group; Industry
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 4,488 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 7
States / cities: Phoenix, Arizona • Long Beach, California • San Jose, California + 4 more

Conditions: Major Depressive Disorder, Depression
Interventions: TC-5214 + citalopram, Placebo + citalopram; Drug
Lead sponsor: Targacept Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 574 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 3
States / cities: Miami, Florida • Cincinnati, Ohio • Dallas, Texas

Conditions: Frailty
Interventions: Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs), Placebo, Penicillin/Streptomycin-Free Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs); Biological
Lead sponsor: Longeveron Inc.; Industry
Eligibility: 60 Years to 95 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Duodenal Neoplasm, Pancreatic Neoplasm
Interventions: Bupivacaine, Hydromorphone, Iopamidol, Liposomal Bupivacaine, Medical Chart Review, Questionnaire Administration, Thoracic Epidural Analgesia, Ultrasound Imaging, X-Ray Imaging; Drug · Other · Procedure
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Stage III (IIIB or IIIC) Colon Cancer
Interventions: Regorafenib, Placebo; Drug
Lead sponsor: NSABP Foundation Inc; Network
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 51
States / cities: Orange, California • Santa Rosa, California • Vallejo, California + 47 more

Conditions: Chronic Bronchitis, Chronic Obstructive Pulmonary Disease
Interventions: Erdosteine; Drug
Lead sponsor: Adams Respiratory Therapeutics; Industry
Eligibility: 40 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2006
U.S. locations: 1
States / cities: King of Prussia, Pennsylvania

Conditions: Postpartum Hemorrhage
Interventions: Placental Blood Drainage, Placenta Blood Not Drained; Procedure
Lead sponsor: University of Tennessee; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Major Depressive Disorder
Interventions: Assay-guided treatment (AGT), Treatment-as-usual (TAU); Genetic · Other
Lead sponsor: Genomind, LLC; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 305 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 23
States / cities: Birmingham, Alabama • Phoenix, Arizona • Springdale, Arkansas + 20 more

Conditions: Obesity
Interventions: Fit and Fab; Behavioral
Lead sponsor: University at Buffalo; Other
Eligibility: 18 Years to 64 Years · Female only
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Hypertension
Interventions: metoprolol succinate; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 6 Years to 16 Years
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2002
U.S. locations: 30
States / cities: Little Rock, Arkansas • Bellflower, California • Beverly Hills, California + 27 more

Conditions: Hemorrhage
Interventions: Methergine, placebo; Drug · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older · Female only
Enrollment: 284 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Inflammatory Bowel Disease, Crohn's Disease, Ulcerative Colitis
Interventions: HealthPROMISE users, Control Group; Other
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Alzheimer's Disease
Interventions: Aducanumab, Placebo; Drug
Lead sponsor: Biogen; Industry
Eligibility: 60 Years to 85 Years
Enrollment: 1,027 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 130
States / cities: Gilbert, Arizona • Phoenix, Arizona • Scottsdale, Arizona + 107 more

Conditions: Sleep Apnea
Interventions: VI-0521, placebo; Drug
Lead sponsor: VIVUS LLC; Industry
Eligibility: 30 Years to 65 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Pain, Burns
Interventions: VR-based Pain Alleviation Tool (VR-PAT); Other
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Diabetic Nephropathy
Interventions: Sevelamer Carbonate, Calcium Carbonate; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity, Insulin Resistance
Interventions: Time-restricted Eating plan, Consistent Meal timing plan; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 64 Years
Enrollment: 137 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Spinal Cord Injury, Spinal Cord Injuries, Trauma, Nervous System, Wounds and Injury, Central Nervous System Diseases, Spinal Cord Diseases, Gonadal Disorders, Endocrine System Diseases, Hypogonadism, Genital Diseases, Male, Spinal Cord Trauma, Injuries, Spinal Cord, Walking, Difficulty, Gait Disorders, Neurologic, Locomotion Disorder, Neurologic, Wounds and Injuries, Nervous System Diseases, Testosterone Deficiency, Androgen Deficiency, Hormone Deficiency
Interventions: Testosterone Enanthate, Locomotor Training; Drug · Behavioral
Lead sponsor: North Florida Foundation for Research and Education; Other
Eligibility: 18 Years and older · Male only
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 2
States / cities: Gainesville, Florida • Jacksonville, Florida

Conditions: Diabetic Ulcer
Interventions: Topical wound oxygen therapy, Topical wound oxygen Placebo; Device
Lead sponsor: AOTI Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Rheumatoid Arthritis
Interventions: AZD1163, Placebo; Drug · Other
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years and older
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 29
States / cities: Glendale, Arizona • Prescott Valley, Arizona • Tucson, Arizona + 25 more

Conditions: Autism Spectrum Disorder (ASD)
Interventions: Wellness Enhancing Physical Activity for Young Children: Parent Version (WE PLAY for Parents); Behavioral
Lead sponsor: Northeastern University; Other
Eligibility: 18 Years and older
Enrollment: 114 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Diabetes
Interventions: Sensor-based exercise training, In-home balance training; Device · Other
Lead sponsor: University of Arizona; Other
Eligibility: 50 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Inflammation, Pain, Cataract
Interventions: XG-102, Placebo; Drug
Lead sponsor: Xigen SA; Industry
Eligibility: 18 Years and older
Enrollment: 339 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Garden Grove, California

Conditions: Heart Failure，Congestive
Interventions: Not listed
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Aurora, Colorado

Search by objective public record fields.

National Prevalence and Impact of Noninvasive Prenatal Testing

TC-5214 as add-on the Treatment of Major Depressive Disorder

AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

A Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Colon Cancer

Phase 2 Study - Erdosteine in Patients With CB/COPD

The Effect of Placental Cord Drainage on Postpartum Blood Loss

Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD

Increasing Exercise Enjoyment and Outcome Expectations Among Women With Obesity

Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects

Uterotonic Prophylaxis Trial

Trial on Impact of HealthPROMISE Mobile App on Inflammatory Bowel Disease Care and Quality of Life

A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

A Study of VI-0521 for the Treatment of Obstructive Sleep Apnea / Hypopnea Syndrome in Obese Adults

VR for Pain Management During Adult Burn Dressing Change

Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy

Study of Time-restricted Eating on Weight Loss.

Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury

Evaluation of Topical Wound Oxygen (two2) Therapy

A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

An Empowering Parent Training Intervention to Increase Physical Activity in Preschool Aged Children With Autism

Sensor-based Balance Training in Diabetes: A Virtual Reality Paradigm

Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation

Effect of mechanIcal circulatoRy Support ON Exercise Capacity aMong pAtieNts With Heart Failure